Back
United Therapeutics Stock Predictions
Buy
55
UTHR
United Therapeutics
Last Price:
272.51
Seasonality Move:
9.04%
7 Day Trial
ALL ACCESS PASS
$
7
United Therapeutics Stock Forecast
- Over the next 52 weeks, United Therapeutics has on average historically risen by 19.9% based on the past 24 years of stock performance.
- United Therapeutics has risen higher in 16 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is United Therapeutics Stock Undervalued?
The current United Therapeutics [UTHR] share price is $272.69. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, United Therapeutics has on average historically risen by 19.9% based on the past 24 years of stock performance.
United Therapeutics Stock Rating
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
- United Therapeutics has risen higher in 16 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
275.00
52-Week Low:
204.44
Prediction Charts
Market Cap:
12.1B
Price in USD:
272.69
Volume:
325.02K
Beta:
0.51
Technical Analysis
SMA50:
242.91
SMA100:
231.36
SMA200:
230.92
52-Wk Change:
27.19%
Stock Predictions
-
Is United Therapeutics stock public?
Yes, United Therapeutics is a publicly traded company. -
What is the United Therapeutics stock quote today?
The United Therapeutics stock price is 272.69 USD today. -
How to buy United Therapeutics stock online?
You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-26 | 236.59 | 233.85 | 237.53 | 233.64 |
Apr-29 | 234.76 | 238.26 | 240.93 | 234.76 |
Apr-30 | 236.28 | 234.90 | 237.76 | 233.31 |
May-1 | 243.00 | 255.02 | 258.48 | 236.65 |
May-2 | 255.10 | 258.11 | 260.34 | 253.93 |
May-3 | 260.33 | 262.40 | 262.51 | 255.93 |
May-6 | 263.63 | 260.51 | 264.85 | 256.08 |
May-7 | 261.41 | 266.35 | 266.65 | 260.93 |
May-8 | 266.38 | 261.09 | 268.21 | 260.66 |
May-9 | 263.87 | 265.91 | 266.38 | 260.41 |
May-10 | 266.00 | 264.27 | 269.81 | 263.93 |
May-13 | 265.93 | 264.34 | 269.10 | 263.56 |
May-14 | 264.35 | 269.78 | 269.83 | 264.35 |
May-15 | 271.11 | 272.69 | 275.00 | 269.93 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.83 per share, and an increase next year of $1.72 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.